• S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

  • May 7 2021
  • Length: 25 mins
  • Podcast

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Listen for free

View show details

  • Summary

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.
    Show More Show Less
Show More Show Less
activate_samplebutton_t1

What listeners say about S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.